Hikma Sees Signs Of A Bounceback For Generics

Now Forecasting Generics Sales Growth Of 20% In 2023, After Taking An 18% Hit In 2022

 
• By David Wallace
  
Rebound - Arrow Down Then Up
Hikma sees its generics business bouncing back in 2023 • Source: Shutterstock

More from Earnings

More from Business